| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 653574 | 67460 | PAROXETINA QUALIGEN FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | PAROXETINA QUALIGEN FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67460/67460_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67460/67460_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2006-01-16 | 1 | 1 | 1 | 2006-01-16 | 2006-01-16 | 1 | 2019-02-14 | View Edit Delete | ||||||||||||
| 652699 | 67237 | GLIMEPIRIDA PENSA 2 mg COMPRIMIDOS EFG | GLIMEPIRIDA PENSA 2 mg COMPRIMIDOS EFG , 30 comprimidos | 2 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67237/67237_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67237/67237_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2005-11-21 | 1 | 1 | 1 | 2005-11-21 | 2005-11-21 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 652700 | 67237 | GLIMEPIRIDA PENSA 2 mg COMPRIMIDOS EFG | GLIMEPIRIDA PENSA 2 mg COMPRIMIDOS EFG , 120 comprimidos | 2 mg | 5 | 120 | 10 | 120 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67237/67237_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67237/67237_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2005-11-21 | 1 | 1 | 1 | 2005-11-21 | 2005-11-21 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 652705 | 67239 | GLIMEPIRIDA PENSA 4 mg COMPRIMIDOS EFG | GLIMEPIRIDA PENSA 4 mg COMPRIMIDOS EFG , 30 comprimidos | 4 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67239/67239_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67239/67239_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2005-11-21 | 1 | 1 | 1 | 2005-11-21 | 2005-11-21 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 652706 | 67239 | GLIMEPIRIDA PENSA 4 mg COMPRIMIDOS EFG | GLIMEPIRIDA PENSA 4 mg COMPRIMIDOS EFG , 120 comprimidos | 4 mg | 5 | 120 | 10 | 120 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67239/67239_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67239/67239_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2005-11-21 | 1 | 1 | 1 | 2005-11-21 | 2005-11-21 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 653404 | 65956 | IBUPROFENO ALDO-UNIÓN 20 mg/ml SUSPENSIÓN ORAL EFG | IBUPROFENO ALDO-UNIÓN 20 mg/ml SUSPENSIÓN ORAL EFG, 1 frasco de 200 ml | 20 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65956/65956_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65956/65956_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2004-03-09 | 1 | 1 | 1 | 2004-03-09 | 2006-09-14 | 1 | 2011-07-14 | 835439 | View Edit Delete | |||||||||||
| 652928 | 67355 | LANSOPRAZOL TARBIS 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL TARBIS 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67355/67355_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67355/67355_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2005-12-13 | 1 | 1 | 1 | 2005-12-13 | 2005-12-13 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 652930 | 67356 | LANSOPRAZOL TARBIS 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL TARBIS 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67356/67356_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67356/67356_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2005-12-13 | 1 | 1 | 1 | 2005-12-13 | 2005-12-13 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 652710 | 67271 | CETIRIZINA TEVA 1 mg/ml SOLUCION ORAL EFG | CETIRIZINA TEVA 1 mg/ml SOLUCION ORAL EFG , 1 frasco de 200 ml | 1 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67271/67271_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67271/67271_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2005-11-28 | 1 | 1 | 1 | 2005-11-28 | 2005-11-28 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 653307 | 66148 | LANSOPRAZOL TEVA-RATIOPHARM 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL TEVA-RATIOPHARM 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas (FRASCO) | 30 mg | 6 | 28 | 43 | 28 cápsulas (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66148/66148_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66148/66148_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2004-06-22 | 1 | 1 | 1 | 2004-06-22 | 2006-06-19 | 1 | 2011-10-07 | 727255, 999852 | View Edit Delete | |||||||||||
| 653512 | 67439 | TIOCONAZOL KORHISPANA 280 mg/ml BARNIZ DE UÑAS MEDICAMENTOSO EFG | TIOCONAZOL KORHISPANA 280 mg/ml BARNIZ DE UÑAS MEDICAMENTOSO EFG, 1 frasco de 12 ml | 280 mg/ml | 6 | 12 | 26 | 1 frasco de 12 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67439/67439_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67439/67439_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10651 | KORHISPANA S.L. | 2006-01-16 | 1 | 1 | 1 | 2006-01-16 | 2006-01-16 | 0 | 2011-04-28 | View Edit Delete | ||||||||||||
| 653122 | 65643 | ARATRO 200 mg/5 ml POLVO PARA SUSPENSION ORAL EN FRASCO EFG | ARATRO 200 mg/5 ml POLVO PARA SUSPENSION ORAL EN FRASCO EFG, 1 frasco de 30 ml | 200 mg/5 ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65643/65643_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65643/65643_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2003-10-03 | 1 | 1 | 1 | 2003-10-03 | 2011-10-28 | 1 | 2011-11-28 | 732107, 653412 | View Edit Delete | |||||||||||
| 653409 | 65643 | ARATRO 200 mg/5 ml POLVO PARA SUSPENSION ORAL EN FRASCO EFG | ARATRO 200 mg/5 ml POLVO PARA SUSPENSION ORAL EN FRASCO EFG, 1 frasco de 15 ml | 200 mg/5 ml | 6 | 15 | 26 | 1 frasco de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65643/65643_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65643/65643_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2003-10-03 | 1 | 1 | 1 | 2003-10-03 | 2006-09-26 | 1 | 2011-11-28 | 731653 | View Edit Delete | |||||||||||
| 653869 | 67576 | LANSOPRAZOL QUALIGEN 15 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL QUALIGEN 15 mg CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67576/67576_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67576/67576_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2006-02-21 | 1 | 1 | 1 | 2006-02-21 | 2006-02-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 653870 | 67577 | LANSOPRAZOL QUALIGEN 30 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL QUALIGEN 30 mg CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67577/67577_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67577/67577_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2006-02-21 | 1 | 1 | 1 | 2006-02-21 | 2006-02-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 653193 | 65753 | AZITROMICINA ALTER 500 mg GRANULADO PARA SUSPENSION ORAL EFG | AZITROMICINA ALTER 500 mg GRANULADO PARA SUSPENSION ORAL EFG, 3 sobres | 500 mg | 35 | 3 | 64 | 3 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65753/65753_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65753/65753_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2003-10-31 | 1 | 1 | 1 | 2003-10-31 | 2006-04-06 | 1 | 2011-11-11 | 764613 | View Edit Delete | |||||||||||
| 654666 | 67916 | IBUPROFENO KERN PHARMA 200 mg GRANULADO EFERVESCENTE EFG | IBUPROFENO KERN PHARMA 200 mg GRANULADO EFERVESCENTE EFG , 20 sobres | 200 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67916/67916_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67916/67916_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-07-04 | 1 | 1 | 1 | 2006-07-04 | 2006-07-04 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 653049 | 71209 | NITROFIX 5 mg PARCHES TRANSDERMICOS EFG | NITROFIX 5 mg PARCHES TRANSDERMICOS EFG, 30 parches | 5 mg/24 h | 35 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71209/71209_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71209/71209_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2009-07-17 | 1 | 1 | 1 | 2009-07-17 | 2011-10-28 | 1 | 2014-05-01 | 663673, 672041 | View Edit Delete | |||||||||||
| 653056 | 71214 | NITROFIX 15 mg PARCHES TRANSDERMICOS EFG | NITROFIX 15 mg PARCHES TRANSDERMICOS EFG, 30 parches | 15 mg/24 h | 35 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71214/71214_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71214/71214_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2009-07-17 | 1 | 1 | 1 | 2009-07-17 | 2011-10-28 | 1 | 2011-11-28 | 663676, 672040 | View Edit Delete | |||||||||||
| 653064 | 71210 | NITROFIX 10 mg PARCHES TRANSDERMICOS EFG | NITROFIX 10 mg PARCHES TRANSDERMICOS EFG, 30 parches | 10 mg/24 h | 35 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71210/71210_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71210/71210_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2009-07-17 | 1 | 1 | 1 | 2009-07-17 | 2011-10-28 | 1 | 2011-11-28 | 663678, 672037 | View Edit Delete |
Page 43 of 1036, showing 20 records out of 20704 total, starting on record 841, ending on 860